Cystic Fibrosis Foundation Drug Development Model Spawns More Than 30 Promising Therapies
Revised Law Includes Designated Funding for Rare Diseases
Nonprofit issues challenge to accelerate treatments for every person with CF
Today, the Cystic Fibrosis Foundation announced that it has awarded up to $400,000 to Life Edit Therapeutics Inc. to explore the application of their unique gene editing technology in CF.
Funding will support improved detection, diagnosis, prevention, and treatment of infections related to cystic fibrosis.
Collaborative effort identifies 40 cases of COVID-19 across eight countries; outcomes for this high-risk population were reported in the Journal of Cystic Fibrosis